Clinical Trials Browser

Phase 2 × IT-101 × Thoracic × Clear all

NCT01803269 2020-06-26

Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung Cancer

Phase 2 Terminated

29 enrolled 14 charts

Small Cell Lung Carcinoma

NCT01380769 2020-05-28

A Phase 2 Study of CRLX101(NLG207) in Patients With Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

157 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung